A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection
Clinical trial NCT02243293 · COMPLETED
Trial details
- NCT number
- NCT02243293
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-19
- Primary completion
- 2016-10-25
- Enrollment
- 694
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.